首页> 外国专利> Sustained Release composition comprising a water-soluble physiologically Active Peptide uniformly dispersed in a microcapsule

Sustained Release composition comprising a water-soluble physiologically Active Peptide uniformly dispersed in a microcapsule

机译:包含均匀分散在微胶囊中的水溶性生理活性肽的缓释组合物

摘要

1.A sustained-release composition in which a physiologically active substance comprising a water-soluble physiologically Active Peptide is dispersed into a substantially uniform in a microcapsule comprising a polymer of lactic acid or its Salts,Where a physiologically active substance is contained in an amount of 15 to 35% (weight / weight) with respect to the total microcapsules, and the weight Average Molecular Weight (MP) of the polymer of lactic acid is approximately 11000 to approximately 27.000.2.The sustained Release composition according to claim 1, wherein the weight Average Molecular Weight (MP) of the polymer of lactic acid is any one selected from: (i) approximately 11600 to approximately 20000 and (ii) approximately 19000 to approximately At 27000. 3.The sustained Release composition according to claim 2, wherein the weight Average Molecular Weight of the polymer (MP) (i) of lactic acid is approximately 11600 approximately 20.000, which includes maintaining an effective level of the drug in blood for a period of 60 days to approximately 130 Days of release in vivo of the physiologically active substance Composition of sustained release. 4.The sustained Release composition according to claim 2, wherein the weight Average Molecular Weight of the polymer (MP) (ii) of lactic acid is approximately 19000 to approximately 27.000, which includes maintaining an effective level of drug in blood for a period of 120 days to approximately 400 days for release in vivo of the physiologically active substance Composition of sustained release. 5. - the sustained Release composition according to claim 1, wherein the physiologically active substance is a Derivative of lh-rh. 6.The sustained Release composition according to claim 1, wherein the physiologically active substance is a Peptide formula: 5 - oxo - Pro - His - Trp - Leu - Tyr and ARG pro Zen where and represents dleu, dala, dtrp, dser (tBu), d2nai DHIS (or lmbzl) and Z represents NH - C2H5 or Gly n H2, or a Salt thereof.
机译:1.一种缓释组合物,其中包含水溶性生理活性肽的生理活性物质在包含乳酸或其盐的聚合物的微胶囊中基本均匀地分散,其中以一定量包含生理活性物质相对于总微胶囊为15至35%(重量/重量)的乳酸,并且乳酸聚合物的重均分子量(MP)为约11000至约27.000.2。 3.根据权利要求1所述的缓释组合物,其中所述乳酸的聚合物的重均分子量(MP)选自:(i)约11600至约20000和(ii)约19000至约27000。参照图2,其中乳酸的聚合物(MP)(i)的重均分子量为约11600约20.000,这包括保持有效的l药物在血液中的释放时间为60天至大约130天,体内的生理活性物质的组成是持续释放的。 4.根据权利要求2所述的持续释放组合物,其中所述乳酸的聚合物(MP)(ii)的重均分子量为约19000至约27.000,其包括在一段时间内保持血液中药物的有效水平。在体内释放120天至约400天的持续释放的生理活性物质组合物。 5.根据权利要求1所述的持续释放组合物,其中所述生理活性物质是1h-rh的衍生物。 6.根据权利要求1所述的持续释放组合物,其中所述生理活性物质是肽式:5-氧代-Pro-His-Trp-Leu-Tyr和ARG pro Zen,其中和代表dleu,dala,dtrp,dser(tBu ),d2nai DHIS(或lmbzl)和Z代表NH-C2H5或Gly n H2或其盐。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号